$1,053.79
Value $104B
EQIX and UHT stock compared: price, dividend, valuation and results, from SEC filings.
$1,053.79
Value $104B
$38.86
Value $539M
Equinix (EQIX) has a market value of $104B and Universal Health Realty Income Trust (UHT) $539M. Over the last year, with dividends, EQIX moved +32.3% and UHT +6.2%. The P/E is 62.8 for EQIX and 26.7 for UHT. Dividend yield: EQIX 1.91%, UHT 7.70%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
EQIX$104B
UHT$539M
EQIX is 192 times UHT
Revenue, 12 months
EQIX$10.1B
UHT$99M
EQIX is 101 times UHT
Net income, 12 months
EQIX$1.6B
UHT$20M
EQIX is 82 times UHT
Operating margin
EQIX22.5%
UHT35.9%
13.4 points apart
ROIC
EQIX5.9%
UHT5.6%
0.3 points apart
P/E
EQIX62.8
UHT26.7
EQIX is 2.4 times UHT
Dividend yield
EQIX1.9%
UHT7.7%
5.8 points apart
5-year return
EQIX+50.1%
UHT-7.6%
57.7 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
EQIX+50.1%
UHT-7.6%
| Period | EQIXWith dividends | UHTWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +32.3%Price +29.6% | +6.2%Price -1.5% |
| 3 years since November 13, 2023 | +47.2%+13.8% a yearPrice +38.2% | +24.3%+7.5% a yearPrice -0.3% |
| 5 years since November 12, 2021 | +50.1%+8.5% a yearPrice +35.9% | -7.6%-1.6% a yearPrice -33.9% |
| 10 years since November 15, 2016 | +277.9%+14.2% a yearPrice +213.3% | +18.7%+1.7% a yearPrice -29.6% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
EQIXEquinixUHTUniversal Health Realty Income Trust
| Price | $1,053.79 | $38.86 |
|---|---|---|
| Market value | $104B | $539M |
| Enterprise value (EV) | $125B | $910M |
| P/E | 62.8 | 26.7 |
| P/E, 5-year median | 78.1 | 30.9 |
| P/B | 7.1 | 3.9 |
| EV/EBIT | 55.3 | 25.6 |
| Free cash flow yield | – | – |
| Revenue, 12 months | $10.1B | $99M |
|---|---|---|
| Net income, 12 months | $1.6B | $20M |
| Free cash flow, 12 months | -$1.7B | – |
| Earnings per share, 12 months | $16.65 | $1.45 |
| Revenue growth, year on year | 5.4% | 0.2% |
| Revenue growth a year, past | +9.0%over 5 years | +4.9%over 5 years |
| EPS growth a year, past | +26.9%over 5 years | -2.1%over 5 years |
| Gross margin | 51.6% | – |
|---|---|---|
| Operating margin | 22.5% | 35.9% |
| Net margin | 16.4% | 20.3% |
| ROIC | 5.9% | 5.6% |
| ROE | 11.5% | 13.6% |
| Cash | $3.6B | $6.5M |
|---|---|---|
| Total debt | $26.6B | $389M |
| Net debt / EBITDA | 5.0 | 5.8 |
| Interest cover | 3.8× | – |
| Dividend yield | 1.9% | 7.7% |
|---|---|---|
| Dividend per share, 12 months | $20.17 | $2.99 |
| Dividend growth a year, past | +12.0%over 5 years | +1.4%over 5 years |
| Buyback yield | – | 0.0% |
| Shareholder yield | 1.9% | 7.7% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Equinix ($104B) is about 192.0 times Universal Health Realty Income Trust ($539M), at today's prices.
Since November 15, 2016, EQIX's price moved +213.3% and UHT's -29.6%. With dividends: EQIX +277.9% (+14.2% a year), UHT +18.7% (+1.7% a year). Past returns do not predict future ones.
The dividend yield at today's price is 1.91% for Equinix and 7.70% for Universal Health Realty Income Trust. Over the last twelve months they paid $20.17 and $2.99 per share.
At today's price, the P/E is 62.8 for EQIX and 26.7 for UHT. The median of the last five years was 78.1 and 30.9, which shows where each stands against its own past.
Over the last twelve months, the net margin was 16.4% for Equinix and 20.3% for Universal Health Realty Income Trust, and the operating margin 22.5% and 35.9%. Revenue was $10.1B and $99M.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.